Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open-label Placebos”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01651143
What this trial is testing

Proof of Biological Activity of SAR100842 in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Sanofi 32
Testing effectiveness (Phase 2)Study completedNCT00422552
What this trial is testing

Effect of Indacaterol on Inspiratory Capacity and Lung Function in Patients With COPD Versus Placebo and Formoterol

Who this might be right for
COPD
Novartis 30
Testing effectiveness (Phase 2)Study completedNCT05357950
What this trial is testing

A Phase IIb, Multi-Center, Multinational, Double-Blind, Placebo-Controlled Study, With an Open Label Extension, to Evaluate Safety, Tolerability and Efficacy of PrimeC in Subjects With ALS

Who this might be right for
Amyotrophic Lateral SclerosisALS
NeuroSense Therapeutics Ltd. 69
Testing effectiveness (Phase 2)Study completedNCT02129777
What this trial is testing

Efficacy and Safety of Namilumab (MT203) for Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Takeda 122
Testing effectiveness (Phase 2)Study completedNCT03845075
What this trial is testing

48 Weeks, Study to Evaluate Overall Safety and Tolerability of Co-administration of Tesofensine and Metoprolol in Subjects With Hypothalamic Injury-induced Obesity (HIO)

Who this might be right for
Hypothalamic Injury-induced Obesity (HIO)
Saniona 21
Large-scale testing (Phase 3)Study completedNCT02333071
What this trial is testing

1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder

Who this might be right for
Hypoactive Sexual Desire Disorder
Palatin Technologies, Inc 723
Post-approval studies (Phase 4)Study completedNCT00580840
What this trial is testing

Dosing Flexibility Study in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
UCB Pharma 333
Large-scale testing (Phase 3)Study completedNCT04486508
What this trial is testing

Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19

Who this might be right for
Covid19
Rajaie Cardiovascular Medical and Research Center 600
Not applicableUnknownNCT02991235
What this trial is testing

Efficacy and Safety of PRJ212 to Improve the Memory of Patients With Mild Severity Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Bioiberica 30
Testing effectiveness (Phase 2)Study completedNCT05107115
What this trial is testing

Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine

Who this might be right for
Chronic Spontaneous Urticaria
Sanofi 160
Large-scale testing (Phase 3)Study completedNCT05693935
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With Schizophrenia

Who this might be right for
Schizophrenia
Teva Branded Pharmaceutical Products R&D LLC 675
Testing effectiveness (Phase 2)Study completedNCT00783094
What this trial is testing

Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label Extension

Who this might be right for
Benign Prostatic Hyperplasia
Eli Lilly and Company 422
Testing effectiveness (Phase 2)Active Not RecruitingNCT05060822
What this trial is testing

Phase ll Study of HEC585 in Patients With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Sunshine Lake Pharma Co., Ltd. 270
Large-scale testing (Phase 3)Study completedNCT00023153
What this trial is testing

Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection

Who this might be right for
HIV InfectionsChronic Hepatitis B
National Institute of Allergy and Infectious Diseases (NIAID) 100
Large-scale testing (Phase 3)Study completedNCT01438840
What this trial is testing

Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02)

Who this might be right for
Chronic ThrombocytopeniaImmune Thrombocytopenia
Eisai Inc. 49
Large-scale testing (Phase 3)Study completedNCT00463242
What this trial is testing

A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder
Novartis 501
Large-scale testing (Phase 3)Study completedNCT01191086
What this trial is testing

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Who this might be right for
Epilepsy
Upsher-Smith Laboratories 210
Large-scale testing (Phase 3)Study completedNCT01762761
What this trial is testing

Eltrombopag Phase III Study In Chinese Chronic ITP Patients

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic and Hepatitis C
Novartis Pharmaceuticals 155
Large-scale testing (Phase 3)Study completedNCT00359905
What this trial is testing

Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH

Who this might be right for
Benign Prostatic Hyperplasia
RECORDATI GROUP 1,228
Large-scale testing (Phase 3)Active Not RecruitingNCT06616194
What this trial is testing

Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine

Who this might be right for
Migraine
Pfizer 200
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation